1. Home
  2. CYTK vs WFG Comparison

CYTK vs WFG Comparison

Compare CYTK & WFG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CYTK
  • WFG
  • Stock Information
  • Founded
  • CYTK 1997
  • WFG 1955
  • Country
  • CYTK United States
  • WFG Canada
  • Employees
  • CYTK N/A
  • WFG N/A
  • Industry
  • CYTK Biotechnology: Pharmaceutical Preparations
  • WFG
  • Sector
  • CYTK Health Care
  • WFG
  • Exchange
  • CYTK Nasdaq
  • WFG Nasdaq
  • Market Cap
  • CYTK 5.6B
  • WFG 6.0B
  • IPO Year
  • CYTK 2004
  • WFG N/A
  • Fundamental
  • Price
  • CYTK $32.00
  • WFG $73.44
  • Analyst Decision
  • CYTK Buy
  • WFG Buy
  • Analyst Count
  • CYTK 15
  • WFG 3
  • Target Price
  • CYTK $73.71
  • WFG $105.00
  • AVG Volume (30 Days)
  • CYTK 2.0M
  • WFG 151.0K
  • Earning Date
  • CYTK 05-06-2025
  • WFG 07-23-2025
  • Dividend Yield
  • CYTK N/A
  • WFG 1.74%
  • EPS Growth
  • CYTK N/A
  • WFG N/A
  • EPS
  • CYTK N/A
  • WFG N/A
  • Revenue
  • CYTK $19,218,000.00
  • WFG $6,006,000,000.00
  • Revenue This Year
  • CYTK $24.01
  • WFG $1.36
  • Revenue Next Year
  • CYTK $698.33
  • WFG $8.10
  • P/E Ratio
  • CYTK N/A
  • WFG N/A
  • Revenue Growth
  • CYTK 412.21
  • WFG N/A
  • 52 Week Low
  • CYTK $29.31
  • WFG $69.48
  • 52 Week High
  • CYTK $61.38
  • WFG $102.40
  • Technical
  • Relative Strength Index (RSI)
  • CYTK 44.20
  • WFG 46.25
  • Support Level
  • CYTK $30.02
  • WFG $72.85
  • Resistance Level
  • CYTK $31.27
  • WFG $74.40
  • Average True Range (ATR)
  • CYTK 1.32
  • WFG 1.49
  • MACD
  • CYTK 0.38
  • WFG -0.06
  • Stochastic Oscillator
  • CYTK 72.12
  • WFG 24.88

About CYTK Cytokinetics Incorporated

Cytokinetics Inc is a biotechnology company that develops muscle biology-driven treatments for diseases characterized by reduced muscle function, muscle weakness, and fatigue. The company develops treatments for diseases such as amyotrophic lateral sclerosis, heart failure, spinal muscular atrophy, and chronic obstructive pulmonary diseases. The treatment is based on small molecules specifically engineered to increase muscle function and contractility. The company is developing muscle-directed investigational medicines that may potentially improve the health span of people with devastating cardiovascular and neuromuscular diseases of impaired muscle function.

About WFG West Fraser Timber Co. Ltd Common stock

West Fraser Timber is a softwood lumber company that also produces wood panels and pulp products. The company produces its wood products globally, with lumber mills in British Columbia, Alberta, Europe, and the Southeastern United States. Following its acquisition of Norbord in 2021, West Fraser is now one of the largest oriented strand board producers in the world.

Share on Social Networks: